1. Interplay between Transcription Factors and the Epigenome: Insight from the Role of RUNX1 in Leukemia
    Kate H. Brettingham-Moore et al, 2015, Front. Immunol. CrossRef
  2. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia
    Sai Huang et al, 2016, Chin Med J CrossRef
  3. Histone Deacetylases
    Sabnam Parbin et al, 2014, J Histochem Cytochem. CrossRef
  4. The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V
    S Agarwal et al, 2015, Oncogene CrossRef
  5. RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
    K Ponnusamy et al, 2015, Oncogenesis CrossRef
  6. Chromatin Dynamics during Differentiation of Myeloid Cells
    Jörg Schönheit et al, 2015, Journal of Molecular Biology CrossRef
  7. Human DMTF1β antagonizes DMTF1α regulation of the p14ARF tumor suppressor and promotes cellular proliferation
    Mario P. Tschan et al, 2015, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
  8. Evolved Cellular Mechanisms to Respond to Genotoxic Insults: Implications for Radiation-Induced Hematologic Malignancies
    Courtney J. Fleenor et al, 2015, Radiation Research CrossRef
  9. Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells
    Hui Hui et al, 2016, J Cancer Res Clin Oncol CrossRef
  10. Molecular biomarkers in acute myeloid leukemia
    Jeanette Prada-Arismendy et al, 2017, Blood Reviews CrossRef
  11. Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase
    Caroline Schoenherr et al, 2019, PLoS ONE CrossRef
  12. Changes of signal transductivity and robustness of gene regulatory network in the carcinogenesis of leukemic subtypes via microarray sample data
    Cheng-Wei Li et al, 2018, Oncotarget CrossRef
  13. TRIB2 contributes to cisplatin resistance in small cell lung cancer
    Yuanxin Liang et al, 2017, Oncotarget CrossRef
  14. AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms
    Kai Rejeski et al, 2021, Oncogene CrossRef
  15. Activated and nonactivated MSCs increase survival in humanized mice after acute liver injury through alcohol binging.
    Juan Carlos Hernandez et al, 2022, Hepatol Commun CrossRef
  16. null
    Nurdan Kelesoglu et al, 2022 CrossRef
  17. Melatonin promotes differentiation and apoptosis of AML1-ETO-positive cells
    Xuling Liu et al, 2023, Bulletin du Cancer CrossRef
  18. Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
    Keyuan Zhang et al, 2023, Blood Cancer J. CrossRef
  19. Label-Free Identification of AML1-ETO Positive Acute Myeloid Leukemia Using Single-Cell Raman Spectroscopy
    Yang Wang et al, 2024, Appl Spectrosc CrossRef